HELIX, INC. for HELIX, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 5, 2023 | $40,000 | Replaced |
| 2nd Quarter - Amendment | Jul 26, 2023 | $130,000 | Yes |
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
pharmacogenomic testing, insurance coverage for whole exome sequencing and specific genetic tests
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES | — |
Medical/Disease Research/Clinical Labs MED
COVID-19, Disease X and other respiratory pathogen sequencing and countermeasure development
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES New | — |
Budget/Appropriations BUD
Funding for viral sequencing and surveillance, including from human blood and spital samples
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES | — |
Science/Technology SCI
Viral surveillance and viral sequencing
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES | — |
Defense DEF
Biosecurity efforts around viral surveillance and sequencing for known and unknown pathogens
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES | — |
Homeland Security HOM
Biosecurity and identification of unknown pathogens
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.